Novo Holdings at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Novo Holdings takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions cover what makes a global biotech hub work and where the respiratory market goes beyond the inhaler. The respiratory session is shared with Chiesi and Vicore Pharma.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Novo Holdings Hellerup, Denmark | |
Life-science investment company that manages the Novo Nordisk Foundation's assets, investing in companies from early-stage biotech to mature healthcare businesses. | Panel Mon Nov 9 16:15–17:00 Building the Next Global Biotech Hubs: What Makes an Innovation Ecosystem Work? What makes a region a strong biotech hub, from talent, labs and funding to links with global drug companies. Panel Wed Nov 11 09:00–09:45 Beyond the inhaler: The respiratory market New drugs and targets for asthma, chronic obstructive lung disease and pulmonary fibrosis, and where investors and partners are now putting money. |
Instantly find 20 buyers from Novo Holdings
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction